The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4857 results found.

Example of search result explained

Taro-Tofacitinib XR

Exceptional medication

Active ingredient(s):

tofacitinib citrate
Manufactured by:

Taro Pharmaceuticals Inc. (Taro)
Strength and dosage form:

Long-Action Tablet 11 mg DIN : 2553988

Steqeyma

Exceptional medication

Active ingredient(s):

ustekinumab (ulcerative colitis and Crohn's disease)
Manufactured by:

Celltrion Healthcare Canada Limited (Celltrion)
Strength and dosage form:
Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114386

Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114387

Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2550261

Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114512

Wezlana

Exceptional medication

Active ingredient(s):

ustekinumab (plaque psoriasis children)
Manufactured by:

Amgen Canada Inc. (Amgen)
Strength and dosage form:
Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114450

Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114448

Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114447

Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 99114445

Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 99114446

Hulio (syringe)

Exceptional medication

Active ingredient(s):

adalimumab
Manufactured by:

Biocon Biologics Canada Inc. (Biocon)
Strength and dosage form:
Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2502380

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2502399

Hulio (pen)

Exceptional medication

Active ingredient(s):

adalimumab
Manufactured by:

Biocon Biologics Canada Inc. (Biocon)
Strength and dosage form:

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2502402

Hulio (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (ulcerative colitis-children)
Manufactured by:

Biocon Biologics Canada Inc. (Biocon)
Strength and dosage form:
Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114162

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114161

Hulio (pen)

Exceptional medication

Active ingredient(s):

adalimumab (ulcerative colitis-children)
Manufactured by:

Biocon Biologics Canada Inc. (Biocon)
Strength and dosage form:

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114163

Hulio (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (hidradenitis suppurativa)
Manufactured by:

Biocon Biologics Canada Inc. (Biocon)
Strength and dosage form:
Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114041

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114042

Hulio (pen)

Exceptional medication

Active ingredient(s):

adalimumab (hidradenitis suppurativa)
Manufactured by:

Biocon Biologics Canada Inc. (Biocon)
Strength and dosage form:

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114043

Hulio (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Biocon Biologics Canada Inc. (Biocon)
Strength and dosage form:
Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114104

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114105

Taro-Tofacitinib XR

Steqeyma

Wezlana

Hulio (syringe)

Hulio (pen)

Hulio (syringe)

Hulio (pen)

Hulio (syringe)

Hulio (pen)

Hulio (syringe)

How did we do?